InsidersTradesSigma
Discover the detailed record of transactions filed by BROIDRICK AMY S., Président/Directeur Scientifique. Director active across 1 company, notably Qualigen Therapeutics, Inc.. Aggregated, 1 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €18k. History available since 14 June 2022. The latest transaction was filed on 14 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Amy S. Broidrick is the President and Chief Scientific Officer at Qualigen Therapeutics, Inc. She is responsible for the scientific and strategic leadership of the company, overseeing research and development initiatives. Her expertise in the pharmaceutical field is essential in guiding innovation and growth.